Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-342-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral toxicity of the test item was determined by the Acute Toxic Class Method in female Sprague-Dawley rats. Three animals were administered a single oral dose of 5000 mg/kg body weight (bw) by intubation. Mortality, clinical signs of toxicity and body weight were observed for 14 days following administration. Mortality was not observed at any tested dose level, and the LD50 was expected to be >5000 mg/kg bw. Chromaturia, compound-coloured stool, decrease in locomotor activity, decrease of faecal volume, mucous stool, soiled perineal region, abnormal gait and alterations in body weight observed on Days 1 to 3 were considered test substance related. Conducted according to OECD 423, GLP and considered reliable without restriction (Klimisch 1), there is no evidence of a relevant intrinsic acute oral toxicity requiring classification or substance specific risk mitigation measures (RMM).
The acute dermal toxicity of the test item was determined in a limit test with male and female Sprague-Dawley rats (2000). There were no mortalities observed over the 14-day observation period, therefore the LD50 was determined to be >2000 mg/kg bodyweight. No signs of dermal irritation, clinical signs of toxicity or abnormal bodyweight changes were observed throughout the study duration. Conducted according to OECD 402, GLP and considered reliable without restriction (Klimisch 1), there is no evidence of a relevant intrinsic acute dermal toxicity requiring classification or substance specific RMM.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5 April 2016 - 25 April 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- An assessment of acute toxicity is required to fulfil REACH Annex VII information requirements. The acute oral toxicity study was conducted according to OECD TG 423, GLP and is considered reliable without restriction (Klimisch 1).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Species, strain: Sprague-Dawley (Crl:CD(SD)), SPF
- Age at study initiation: 8 weeks
- Weight at study initiation: 179.9-190.2 g
- Fasting period before study: Approximately 16 hours
- Housing: Housed individually in stainless wire mesh cages (260 x 350 x 210 mm)
- Diet (e.g. ad libitum): Pelleted rodent chow, ad libitum
- Water (e.g. ad libitum): Public tap water in Cheongju-si was filtered and irradiated by ultraviolet light and provided ad libitum.
- Acclimation period: 4 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.1−23.2°C
- Humidity (%): 45.1−54.2%
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12 hour light/dark cycle, 150-300 Lux - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 500 mg/mL
- Lot/batch no. (if required): MKBV2080V
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
DOSAGE PREPARATION (if unusual): The test item was weighed into a bottle and a small amount of corn oil was added. The test item was dissolved using a vortex mixer. Corn oil was gradually added to yield the desired concentration.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Due to the low expected toxicity of the test substance, based on information supplied by the sponsor, a starting dose of 5,000 mg/kg was administered in one animal for this study (Step 1). - Doses:
- 5000 mg/kg bodyweight
- No. of animals per sex per dose:
- 1 for Step 1, 2 for Step 2
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were observed for mortality, general condition and clinical signs (type, severity, time of onset and recovery) at 30 minutes after dosing and at 1, 2, 4 and 6 hours after dosing on Day 0 and once daily thereafter for 14 days (Day 1−Day 14). The body weight was recorded prior to dosing on Day 0 and on Days 1, 3, 7 and on the day of necropsy, Day 14.
- Necropsy of survivors performed: Yes
- Other examinations performed: clinical signs and body weight - Statistics:
- Statistical analysis was not performed. Mean scores and values are determined.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- All animals at 5,000 mg/kg survived the duration of the study. There were no effects on mortality.
- Clinical signs:
- other: Chromaturia (abnormal colour of the urine) were observed in all animals at 6 hours after dosing at 5,000 mg/kg. Chromaturia, compound-coloured stool, decrease in locomotor activity, decrease of faecal volume, mucous stool, soiled perineal region and/or ab
- Gross pathology:
- No abnormal morphological findings were observed in any animal at 5,000 mg/kg.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute oral toxicity study conducted according to OECD TG 423, GLP and considered reliable without restriction (Klimisch 1), the LD50 (cut-off) was determined to be ≥ 5,000 mg/kg bw.
- Executive summary:
The acute oral toxicity of the test item was determined by the Acute Toxic Class Method in female Sprague-Dawley rats. Three animals were administered a single oral dose of 5000 mg/kg body weight (bw) by intubation. Mortality, clinical signs of toxicity and body weight were observed for 14 days following administration. Mortality was not observed at any tested dose level, and the LD50 was expected to be >5000 mg/kg bw. Effects considered to be test substance related included chromaturia, compound-colored stool, decrease in locomotor activity, decrease of fecal volume, mucous stool, soiled perineal region, abnormal gait, suppression of body weight gain and/or decreased bodyweights on Days 1 and 2.
This study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 423. There is no evidence of a relevant intrinsic acute oral toxicity requiring classification or substance specific risk mitigation measures (RMM).
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1 July 1981
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- Summary page of experimental details and results only.
- Justification for type of information:
- An assessment of acute toxicity is required to fulfil REACH Annex VII information requirements. Whilst the study was not considered reliable, due to insufficient reporting, in accordance with Annex VI, all existing information should be evaluated prior to the conduct of in vivo testing.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: A single dose of the test item was administered by oral gavage. Test animals were observed for 14 days following exposure.
- Short description of test conditions: Rats were administered the test item (3.16, 4.64, 6.81, 8.25 or 10.00 ml/kg bw) in a constant volume of 20 mL/kg body weight of the test item in 0.8% aqueous hydroxypropyl-methylcellulose gel.
- Parameters analysed / observed: Number of dead animals, clinical signs of toxicity - GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Standard conditions
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.8% hydroxypropyl-methylcellulose gel
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bodyweight
- Doses:
- 3.16, 4.64, 6.81, 8.25, 10.00 mL/kg
- No. of animals per sex per dose:
- 2
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Not reported
- Necropsy of survivors performed: No
- Other examinations performed: Clinical signs and pathology - Statistics:
- The LD50 was determined graphically.
- Sex:
- male
- Dose descriptor:
- LD100
- Effect level:
- 10 mL/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 8.25 mL/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- 6.81 mL/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- 4.64 mL/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- 3.16 mL/kg bw
- Based on:
- test mat.
- Mortality:
- One animal died when dosed at 8.25 mL/kg bodyweight. Two animals died when dosed at 10.00 mL/kg bodyweight.
- Clinical signs:
- other: - Duration of observation period following administration: 14 days - Frequency of observations and weighing: Not reported - Necropsy of survivors performed: No - Other examinations performed: Clinical signs and pathology - Decreased motility - Ataxia - Un
- Gross pathology:
- Liver and kidneys were pale.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The LD50 of the test item was graphically determined to be 8.25 mL/kg bodyweight.
- Executive summary:
The acute oral toxicity of the test item was determined in a 14-day study. Male mice were given a single dose of the test item in 0.8% hydroxypropyl-methylcellulose gel by oral intubation. Doses were administered at a constant volume of 20 mL/kg bodyweight at test item concentrations of 3.16, 4.64. 6.8, 8.25 and 10.00 mL/kg bw. Each treatment was tested in duplicate. The LD50 of the test item was graphically determined to be 8.25 mL/kg bw. Mice showed signs of decreased motility, ataxia, unusual positions, dyspnoea, lacrimation and tonic spasms. The reliability of this study was not assignable (Klimisch 4), as only a summary page of experimental protocols and results is available. The study was not considered sufficient to fulfil REACH Annex VII information requirements.
Referenceopen allclose all
Table 1. Mortality results
Test item dose (mL/kg) | Number of animals tested | Number of dead animals |
3.16 | 2 | 0 |
4.64 | 2 | 0 |
6.81 | 2 | 0 |
8.25 | 2 | 1 |
10.00 | 2 | 2 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Two acute oral toxicity studies are available (1981, 2016). The key study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 423. The reliability of supporting study cannot be assigned (Klimisch 4), due to insufficient reporting.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 April 2000 - 24 April 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- An assessment of acute toxicity is required to fulfil REACH Annex VII information requirements. The acute dermal toxicity study was conducted according to OECD TG 402, GLP and is considered reliable without restriction (Klimisch 1).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Version / remarks:
- 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Species, Strain: Sprague-Dawley CD (Crl:CD (SD) IGS BR)
- Age at study initiation: 8-12 weeks old
- Weight at study initiation: Males - 200-218 g. Females - 201-221 g
- Housing: Suspended polypropylene cages furnished with woodflakes
- Diet: Rat and Mouse Expanded Diet No.1, ad libitum
- Water: Mains drinking water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Back and flanks
- % coverage: 10
- Type of wrap if used: Surgical gauze semi-occluded with a piece of self-adhensive bandage
REMOVAL OF TEST SUBSTANCE
- Washing: Wiped with cotton wool moistened with arachis oil BP
- Time after start of exposure: 24 hours
TEST MATERIAL
- Concentration: 2000 mg/kg bodyweight - Duration of exposure:
- 24 hour exposure, with a 14-day observation period
- Doses:
- 2000 mg/kg bodyweight
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 0.5, 1, 2 and 4 hours after dosing, then once daily for 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: Mortality, clinical signs, dermal reactions, body weight - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- no indication of skin irritation up to the relevant limit dose level
- Mortality:
- No deaths
- Clinical signs:
- other: No clinical signs of toxicity were noted during the study.
- Gross pathology:
- No abnormalities were noted at necropsy.
- Other findings:
- No signs of dermal Irritation were noted during the study.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 of the test item was determined to be > 2000 mg/kg bodyweight.
- Executive summary:
The acute dermal toxicity of the test item was determined in a limit test with male and female Sprague-Dawley rat. The backs and flanks of the animals were shorn and the test material was applied unchanged at a dosage of 2000 mg/kg bodyweight. The treatment sites were semi-occluded and rats were exposed to the test item for 24 hours. Mortality, clinical signs of toxicity, dermal reactions and body weight were observed for 14 days following treatment. There were no mortalities observed, therefore the LD50 was determined to be > 2000 mg/kg bodyweight. No signs of dermal irritation, clinical signs of toxicity or abnormal bodyweight changes were observed throughout the study duration. This study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 402.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- One acute dermal toxicity studies is available (2000). This study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 402.
Additional information
The acute oral toxicity of the test item was determined by the Acute Toxic Class Method using female Sprague-Dawley rats (2016). One test animal in Step 1 and two test animals in Step 2 were given a single dose of the test item at a concentration of 5000 mg/kg bodyweight by oral intubation. Mortality, clinical signs of toxicity and body weight were observed for 14 days following administration. There were no mortalities observed, therefore the LD50 (cut-off) was determined to be ≥5000 mg/kg b.w. This study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 423, and is therefore sufficient to meet the Annex VII information requirement.
Another 14 -day acute oral toxicity study is available as supporting data (1981). Male mice were given a single dose of the test item in 0.8% hydroxypropyl-methylcellulose gel by oral intubation. Doses were administered at a constant volume of 20 mL/kg bodyweight at test item concentrations of 3.16, 4.64. 6.8, 8.25 and 10.00 mL/kg. Each treatment was tested in duplicate. The LD50 of the test item was graphically determined to be 8.25 mL/kg bodyweight. Rats showed signs of decreased motility, ataxia, unusual positions, dyspnea, lacrimation and tonic spasms. The reliability of this study is not assignable (Klimisch 4) as only a summary page of experimental details and results is available, however it is suitable for use as supporting data to meet the Annex VII information requirement.
The acute dermal toxicity of the test item was determined in a limit test with male and female Sprague-Dawley rats (2000). The backs and flanks of the animals were shorn and the test material was applied unchanged at a dosage of 2000 mg/kg bodyweight. The treatment sites were semi-occluded and rats were exposed to the test item for 24 hours. Mortality, clinical signs of toxicity, dermal reactions and body weight were observed for 14 days following treatment. There were no mortalities observed, therefore the LD50 was determined to be >2000 mg/kg bodyweight. No signs of dermal irritation, clinical signs of toxicity or abnormal bodyweight changes were observed throughout the study duration. This study is considered to be reliable without restrictions (Klimisch 1) as it was GLP-compliant and was performed according to OECD guideline 402, and is therefore sufficient to meet the Annex VII information requirement.
Justification for classification or non-classification
Two key studies (Klimisch 1) are available for acute toxicity classification (2000, 2016). The oral LD50 was determined to be ≥5000 mg/kg bw using the acute toxic class method and the dermal LD50 was determined to be >2000 mg/kg bw in a limit test. Therefore, according to CLP Regulation (EC) No. 1272/2008, the test item should not be classified for acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.